Despite JAM-C being implicated in the pathogenesis of numerous acute and chronic inflammatory conditions (11, 12, 14), we observed no change in the tumor leukocyte infiltration or angiogenesis in EC JAM-C-deficient mice. This evidence concerns the gene JAM3 and neoplasm.